Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension

Summary

Pulmonary arterial hypertension (PAH) can result in right ventricular failure and death. Anakinra has been used in patients with left sided heart failure, and the present study looks to determine if anakinra is safe and effective in patients with PAH. To accomplish this goal, we plan to evaluate for exercise improvement (as assessed by cardiopulmonary exercise testing) in 10 patients with PAH on anakinra.

Timeline

Start

2016-04

Primary completion

2018-06-07

Completion

2018-06-07

Drugs

Indications